Safety and patient satisfaction with outpatient-administered OKT3 in combined kidney/pancreaticoduodenal allograft recipients.
Overman
J A
JA
Organ Transplant Unit, Rochester Methodist Hospital, MN 55902.
Perkins
J D
JD
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D001294:Attitude to Health; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology; D016853:Muromonab-CD3; D010045:Outpatients / Q000523:psychology; D016035:Pancreas Transplantation / Q000276:immunology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3